跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
VIMPAT lacosamide 50 mg film-coated tablets blister pack
Approved
STANDARD
VIMPAT lacosamide 50 mg film-coated tablets blister pack
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
44355ef0fe9a7517
Company
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
Type
Standard
Approval Details
Approval Id
44355ef0fe9a7517
Product Name
VIMPAT lacosamide 50 mg film-coated tablets blister pack
Artg Id
196449
Artg Name
VIMPAT lacosamide 50 mg film-coated tablets blister pack
Sponsor
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
Company Detail Path
/organization/ucb-australia-pty-ltd
Artg Date
2012-07-31
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/3105d459640ea4d7fcfb241405a88dd0.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/581f82d094331087fd059f88c01de91f.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
44355ef0fe9a7517
Type
Standard
Back to TGA Approvals
VIMPAT lacosamide 50 mg film-coated tablets blister pack - TGA Drug Approval Details
